Patents by Inventor Markus Thomas
Markus Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11955021Abstract: The present invention relates generally to a method and system (10) for classifying vehicle behaviour, particularly abnormal behaviour of civil aircraft (12). The method may comprise receiving aircraft data from an aircraft (12) which is to be classified; and determining whether the received aircraft data comprises identification information for the aircraft (12). In response to a determination that the received aircraft data comprises identification information, the method may comprise using said identification information to classify the behaviour of the aircraft (12). In response to a determination that the received aircraft data does not comprises identification information, the method may comprise obtaining the position of the aircraft and comparing the obtained position to an expected route for the aircraft to classify the behaviour of the aircraft (12).Type: GrantFiled: March 13, 2020Date of Patent: April 9, 2024Assignee: BAE SYSTEMS PLCInventors: Benjamin Thomas Chehade, Markus Deittert, Matthew Neil Joseph, Simon Jonathan Mettrick, Yohahn Aleixo Hubert Ribeiro, Frederic Francis Taylor
-
Publication number: 20240108555Abstract: The present invention relates to free-radical-polymerizable compositions and to the use thereof in stereolithography and/or 3D printing, especially for the 3D printing of dental shaped components, such as dental transfer splints, IBTs, transfer keys and drilling templates. The free-radical-polymerizable compositions have the characteristic feature that, after polymerization, they exhibit practically no adhesion to other (meth)acrylic systems.Type: ApplicationFiled: September 14, 2023Publication date: April 4, 2024Inventors: Sebastian Lamping, Markus Nordmann, Daniel Oldenburger, Manfred Thomas Plaumann
-
Publication number: 20240081589Abstract: A floor nozzle apparatus is provided, including a receiving chamber having a receiving space, at least one cleaning roller arranged in the receiving space and rotatable about an axis of rotation, and a suction connector on which a suction stream acts during operation, wherein there is arranged between the receiving space and the suction connector a funnel-shaped duct device opening into the receiving space by an orifice and connecting to the suction connector or including the suction connector, and wherein the orifice has a width, in a direction of width parallel to the axis of rotation, having at least one of the following: (i) the width of the orifice is at least 30% of a width of the receiving space in the direction of width; (ii) the width of the orifice is at least three times a width of an opening in the suction connector in the direction of width.Type: ApplicationFiled: November 17, 2023Publication date: March 14, 2024Inventors: Markus SPROLL, Dominik SCHOLL, Tobias GELTZ, David THOMAS
-
Publication number: 20230399391Abstract: The present invention relates to bispecific antibodies against human VEGF and against human ANG-2, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.Type: ApplicationFiled: January 5, 2023Publication date: December 14, 2023Applicant: Hoffmann-La Roche Inc.Inventors: Monika Baehner, Ulrich Brinkmann, Guy Georges, Remko Albert Griep, Sabine lmhof-Jung, Anita Kavlie, Hubert Kettenberger, Christian Klein, Joerg Thomas Regula, Wolfgang Schaefer, Juergen Michael Schanzer, Werner Scheuer, Stefan Seeber, Markus Thomas
-
Patent number: 11644472Abstract: A method for predicting the risk of recurrence of Atrial Fibrillation in a subject based on measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject is described. Also described is a method of diagnosing Atrial Fibrillation in a subject suspected to suffer from Atrial Fibrillation based on measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. Also described are devices adapted to carry out the method of the present disclosure.Type: GrantFiled: December 12, 2018Date of Patent: May 9, 2023Assignee: Roche Diagnostics Operations, Inc.Inventors: Herbert Andres, Dirk Block, Johann Karl, Peter Kastner, Ursula-Henrike Wienhues-Thelen, Roberto Latini, Serge Masson, Andre Ziegler, Edelgard Kaiser, Stefan Palme, Markus Thomas, Simona Barlera
-
A FIRE RESISTANT VENTILATION DUCT AND A METHOD OF MANUFACTURING AND INSTALLING SUCH VENTIALTION DUCT
Publication number: 20230003333Abstract: A ventilation duct for a fire rated ventilation duct wall penetration has one or more metal sheets forming said duct, wherein said metal sheet duct is covered on the outside by a heat insulating material, and said duct includes elongated stiffening members located on the outside of the duct and attached to said metal sheets. The stiffening members each comprises a metal profile and at least one non-combustible bar of inorganic material. The metal profile is fixed to the metal sheet of the duct and retains the non-combustible bar by at least partly encircling the bar.Type: ApplicationFiled: December 11, 2020Publication date: January 5, 2023Inventors: Kurt Munk Pedersen, Jürg Dieter Stefan Rödenberger, Markus Thoma -
Publication number: 20230005630Abstract: The invention relates to a method and an arrangement for operating a system in which dismantling works are performed underwater in a liquid-filled vessel (10) of a nuclear facility, the liquid being guided in a circuit (20) and flowing through at least one filter device (26, 28, 30). The liquid in the circuit flows through at least a first filter device (26) in the form of a coarse filter and a second filter device (28), in which at least one device from the group of ion exchangers (1, 2, 3), reverse osmosis systems, ultrafiltration systems, activated carbon filters, zeolite filters, and biological filters is used for filtration.Type: ApplicationFiled: December 4, 2020Publication date: January 5, 2023Applicant: SIEMPELKAMP NIS INGENIEURGESELLSCHAFT MBHInventors: Andreas LOEB, Markus THOMA, Markus BECKER, Anna PRÜLLAGE, Laura SCHNEIDER
-
Patent number: 11351407Abstract: The invention relates to an optimized foam former (1) for foaming a foam-water concentrate, which foam former consists of a curved grate having diamond-shaped openings (13) and sharp edges (12). The structure of the foam former increases the foam formation and ensures uniform distribution of the foam over a large area. Existing water sprinklers having a nozzle (3) and a spray disk (2) can be provided with the foam former (1) and thus converted into foam sprinklers in a simple manner. The foam former (1) is arranged in such a way that the foam former (1) protrudes beyond the spray disk (2) toward the nozzle (3).Type: GrantFiled: March 12, 2018Date of Patent: June 7, 2022Assignee: EUROSPRINKLER AGInventors: Markus Thoma, Jens Stubenrauch
-
Publication number: 20210047394Abstract: The present invention relates to bispecific antibodies against human VEGF and against human ANG-2, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.Type: ApplicationFiled: March 13, 2020Publication date: February 18, 2021Applicant: Hoffmann-La Roche Inc.Inventors: Monika Baehner, Ulrich Brinkmann, Guy Georges, Remko Albert Griep, Sabine Imhof-Jung, Anita Kavlie, Hubert Kettenberger, Christian Klein, Joerg Thomas Regula, Wolfgang Schaefer, Juergen Michael Schanzer, Werner Scheuer, Stefan Seeber, Markus Thomas
-
Publication number: 20200199215Abstract: The present invention relates to the combination therapy of an antibodies that binds to human angiopoietin 2 (ANG-2) with a CD40 agonist.Type: ApplicationFiled: February 28, 2020Publication date: June 25, 2020Applicant: Hoffmann-La Roche Inc.Inventors: Christian Klein, Markus Thomas, Alfred Zippelius, Philipp Mueller
-
Publication number: 20200023216Abstract: The invention relates to an optimized foam former (1) for foaming a foam-water concentrate, which foam former consists of a curved grate having diamond-shaped openings (13) and sharp edges (12). The structure of the foam former increases the foam formation and ensures uniform distribution of the foam over a large area. Existing water sprinklers having a nozzle (3) and a spray disk (2) can be provided with the foam former (1) and thus converted into foam sprinklers in a simple manner. The foam former (1) is arranged in such a way that the foam former (1) protrudes beyond the spray disk (2) toward the nozzle (3).Type: ApplicationFiled: March 12, 2018Publication date: January 23, 2020Inventors: Markus Thoma, Jens Stubenrauch
-
Patent number: 10486876Abstract: A product display package for an object includes a display portion and a retaining portion. The display portion includes a frame structure with at least one opening that provides a view of the object when disposed in the product display package. The retaining portion includes a first retaining part and a second retaining part. The first retaining part includes a first holding portion with a first set of ribs configured to engage the object. The first set of ribs is angled with respect to a longitudinal axis of the product display package. The second retaining part is configured to mate with the first retaining part such that the second retaining part is secured to the first retaining part. The second retaining part includes a second holding portion with a second set of ribs configured to engage the object.Type: GrantFiled: June 8, 2017Date of Patent: November 26, 2019Assignees: Robert Bosch Tool Corporation, Robert Bosch GmbHInventors: Adrian Vagnoni, Bobby Brent Boyd, Markus Thomas Rech, Asmus Mueller
-
Publication number: 20190353666Abstract: The present disclosure relates to a method for predicting the risk of recurrence of Atrial Fibrillation in a subject based on determining the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. The present disclosure also contemplates a method of diagnosing Atrial Fibrillation in a subject suspected to suffer from Atrial Fibrillation based on determining the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. Further envisaged are devices adapted to carry out the method of the present disclosure.Type: ApplicationFiled: December 12, 2018Publication date: November 21, 2019Applicant: Roche Diagnostics Operations, Inc.Inventors: Herbert Andres, Dirk Block, Johann Karl, Peter Kastner, Ursula-Henrike Wienhues-Thelen, Roberto Latini, Serge Masson, Andre Ziegler, Edelgard Kaiser, Stefan Palme, Markus Thomas, Simona Barlera
-
Publication number: 20180354693Abstract: A product display package for an object includes a display portion and a retaining portion. The display portion includes a frame structure with at least one opening that provides a view of the object when disposed in the product display package. The retaining portion includes a first retaining part and a second retaining part. The first retaining part includes a first holding portion with a first set of ribs configured to engage the object. The first set of ribs is angled with respect to a longitudinal axis of the product display package. The second retaining part is configured to mate with the first retaining part such that the second retaining part is secured to the first retaining part. The second retaining part includes a second holding portion with a second set of ribs configured to engage the object.Type: ApplicationFiled: June 8, 2017Publication date: December 13, 2018Inventors: Adrian Vagnoni, Bobby Brent Boyd, Markus Thomas Rech, Asmus Mueller
-
Publication number: 20180134780Abstract: The present invention relates to the combination therapy of an antibodies that binds to human angiopoietin 2 (ANG-2) with a CD40 agonist.Type: ApplicationFiled: October 6, 2017Publication date: May 17, 2018Applicant: Hoffmann-La Roche Inc.Inventors: Christian Klein, Markus Thomas, Alfred Zippelius, Philipp Mueller
-
Publication number: 20170369566Abstract: The present invention relates to bispecific antibodies against human VEGF and against human ANG-2, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.Type: ApplicationFiled: May 23, 2017Publication date: December 28, 2017Applicant: Hoffmann-La Roche Inc.Inventors: Monika Baehner, Ulrich Brinkmann, Guy Georges, Remko Albert Griep, Sabine Imhof-Jung, Anita Kavlie, Hubert Kettenberger, Christian Klein, Joerg Thomas Regula, Wolfgang Schaefer, Juergen Michael Schanzer, Werner Scheuer, Stefan Seeber, Markus Thomas
-
Publication number: 20170240626Abstract: The present invention relates to bispecific, bivalent antibodies against human vascular endothelial growth factor (VEGF/VEGF-A) and against human angiopoietin-2 (ANG-2), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.Type: ApplicationFiled: October 4, 2016Publication date: August 24, 2017Applicant: Hoffmann-La Roche Inc.Inventors: Monika Baehner, Sabine Imhof-Jung, Anita Kavlie, Hubert Kettenberger, Christian Klein, Joerg Thomas Regula, Wolfgang Schaefer, Juergen Michael Schanzer, Werner Scheuer, Kay-Gunnar Stubenrauch, Markus Thomas
-
Patent number: 9708396Abstract: The present invention relates to bispecific antibodies against human VEGF and against human ANG-2, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.Type: GrantFiled: February 27, 2014Date of Patent: July 18, 2017Assignee: HOFFMANN-LA ROCHE INC.Inventors: Monika Baehner, Ulrich Brinkmann, Guy Georges, Remko Albert Griep, Sabine Imhof-Jung, Anita Kavlie, Hubert Kettenberger, Christian Klein, Joerg Thomas Regula, Wolfgang Schaefer, Juergen Michael Schanzer, Werner Scheuer, Stefan Seeber, Markus Thomas
-
Publication number: 20150232548Abstract: The present invention relates to the combination therapy of an antibodies that binds to human angiopoietin 2 (ANG-2) with a CD40 agonist.Type: ApplicationFiled: December 18, 2014Publication date: August 20, 2015Applicant: Hoffmann-La Roche Inc.Inventors: Christian Klein, Markus Thomas, Alfred Zippelius, Philipp Mueller
-
Publication number: 20150210018Abstract: A device and corresponding method for producing three-dimensional components from impregnated fiber tapes. The device includes a plurality of grippers, arranged alongside one another, for gripping fiber tapes impregnated with matrix material, the grippers can be displaced in a linear manner on mutually parallel paths between a pick-up position and a maximum position such that the fiber tapes can be tensioned between the grippers and respectively associated transfer devices; a rotatable table on which the fiber tapes can be laid in a first and at least one additional layer; a severing device which can sever the fiber tapes close to the transfer device; a heating device for heating the layers to 160° C. to 400° C.; a first molding tool and one or more additional molding tools which can be moved together to three-dimensionally form the layers; and a transporting device which can transport the heated layers between the molding tools.Type: ApplicationFiled: January 15, 2015Publication date: July 30, 2015Applicants: AUDI AG, VOITH PATENT GMBHInventors: Markus-Thomas Lang, Michael Kaiser, Marco Göttinger, Sebastian Gierl